Procainamide-induced serologic changes in asymptomatic patients.
D000368:Aged; D000974:Antibodies, Antinuclear; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000150:complications; D008297:Male; D008875:Middle Aged; D009223:Myotonic Dystrophy / Q000188:drug therapy; D009504:Neutrophils; D011342:Procainamide / Q000009:adverse effects*; D011802:Quinidine / Q000627:therapeutic use; D012214:Rheumatic Heart Disease / Q000188:drug therapy; D013610:Tachycardia / Q000188:drug therapy
D000974:Antibodies, Antinuclear; D011802:Quinidine; D011342:Procainamide